Lithium Ion

Lithium Ion

SCHEMBL694807

Cc1c(Cl)ccnc1C(=O)[O-].[Li+]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.34
KMO O15229 3/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
HIPK2 Q9H2X6 1/20 0.33
SMARCA2 P51531 1/20 0.33
SMARCA4 P51532 1/20 0.33
KMT2A Q03164 2/20 0.32
SORT1 Q99523 3/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ASPH Q12797 1/20 0.32
KDM8 Q8N371 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL31116884 0.96 DHODH (0.34) DHODHKMOCA1CA2HIPK2
SCHEMBL231248 0.82 KMO (0.47) DHODHKMOKMT2ASORT1MEN1
SCHEMBL31637017 0.82 KMO (0.47) DHODHKMOKMT2ASORT1MEN1
SCHEMBL31636805 0.81 L3MBTL1 (0.46) KMT2AMAPTKDM4E
SCHEMBL14771234 0.81 NPSR1 (0.42) KMOHIPK2KMT2AMAPTKDM4E
Lithium Ion SCHEMBL2065682 0.79 KDM4E (0.42) KMOCA1CA2HIPK2KDM4E
Potassium Ion SCHEMBL29039878 0.78 DAO (0.35) KMOCA1CA2HIPK2KMT2A
SCHEMBL3548766 0.78 MAPT (0.38) DHODHKMT2ASORT1MEN1NPC1
Zinc Ion SCHEMBL28582478 0.77 KDM4E (0.35) KMOCA1CA2HIPK2KMT2A
SCHEMBL2599594 0.75 BRD4 (0.49) NPC1RAB9AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421850-A1 3 -AZABICYCLO [4.1.0]HEPTANES USED AS OREXIN ANTAGONISTS Glaxo Group Limited (GB) 2012-02-29 EP disclosed
WO-2010122151-A1 3 -AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS GLAXO GROUP LIMITED (GB) 2010-10-28 WO disclosed